1 |
Carpentier A, Nashef A, Carpentier S, Ahmed A, Goussef N. Technique for prevention of calcification of valvular bioprosthesis. Circulation 1984;70(Suppl I):165-8
DOI
|
2 |
Nimni ME. The cross-linking and structure modification of the collagen matrix in the design of cardiovascular prosthesis. J Cardiac Surg 1988;3:523-33
DOI
PUBMED
ScienceOn
|
3 |
Zilla P, Weissenstein C, Human P, Dower T, Oppell UO. High glutaraldehyde concentrations mitigate bioprosthetic root calcification in the sheep model. Ann Thorac Surg 2000;70:2091-5
DOI
ScienceOn
|
4 |
Golomb G, Ezra V. Prevention of bioprosthetic heart valve tissue calcification by charge modification: effects of protamine binding by formaldehyde. J Biomed Mater Res 1991;25:85-98
DOI
PUBMED
|
5 |
Gratzer PF, Pereira GA, Lee JM. Solvent environment modulates effects of glutaraldehyde crosslinking on tissue-derived biomaterials. J Biomed Mater Res 1996;31:533-43
DOI
ScienceOn
|
6 |
Wilcox HE, Korossis SA, Booth A, et al. Biocompatibility and recellularization potential of an acellular porcine heart valve matrix. J Heart Valve Dis 2005;14:228-37
PUBMED
|
7 |
Pathak CP, Adams AK, Simpson T, Phillips RE, Moore MA. Treatment of bioprosthetic heart valve tissue with long chain alcohol solution to lower calcification potential. J Biomed Mater Res 2004;69:140-4
|
8 |
Park CS, Kim YJ, Sung SC, et al. Study on an effective decellularization technique for cardiac valve, arterial wall and pericardium xenografts: optimization of decellularization. Korean J Thorac Cardiovasc Surg 2008;41:550-62
|
9 |
Grauss RW, Hazekamp MG, van Vliet S, Gittenberger-de Groot AC, Deruiter MC. Decellularizarion of rat aortic valve allografts reduces leaflet destruction and extracellular matrix remodeling. J Thorac Cardiovasc Surg 2003;126:2003-10
DOI
ScienceOn
|
10 |
Sung SC, Kim YJ, Choi SY, Park JE, Kim KW, Kim WH. A study on an effective decelularization technique for a xenograft cardiac valve: the effect of osmotic treatment with hypotonic solution. Korean J Thorac Cardiovasc Surg 2008;41:679-86
|
11 |
Gratzer PF, Pereira CA, Lee JM. Solvent environment modulates effects of glutaraldehyde crosslinking on tissue-derived biomaterials. J Biomed Mater Res 1996;31:533-43
DOI
ScienceOn
|
12 |
Kim KC, Lee C, Choi CH, et al. Development of porcine pericardial heterograft for clinical application (tensile strength- thickness). Korean J Thorac Cardiovasc Surg 2008;41:170-6
|
13 |
Stein PD, Riddle JM, Kemp SP, et al. Effect of warfarin on calcification of spontaneously degenerated porcine bioprosthetic valves. J Thorac Cardiovasc Surg 1985;90:119-25
PUBMED
|
14 |
Zilla P, Weissenstein C, Human P, Dower T, Oppell UO. High glutaraldehyde concentrations mitigate bioprosthetic root calcification in the sheep model. Ann Thorac Surg 2000;70:2091-5
DOI
ScienceOn
|
15 |
Webb CL, Benedict JJ, Schoen FJ, Linden LA, Levy RJ. Inhibition of bioprosthetic heart valve calcification with aminodiphosphonate covalently bound to residual aldehyde groups. Ann Thorac Surg 1988;46:309-16
DOI
PUBMED
ScienceOn
|
16 |
Sung HW, Hsu CS, Lee YS, Lin DS. Crosslinking characteristics of an epoxy-fixed porcine tendon: effects of pH, temperature, and fixative concentration. J Biomed Mater Res 1998;31:511-8
DOI
ScienceOn
|
17 |
Opie JC, Larrieu AJ, Cornell IS. Pericardial substitutes: delayedexploration and findings. Ann Thorac Surg 1987;3:383-5
|